Application of lag-time into exposure definitions to control for protopathic bias

Pharmacoepidemiology and Drug Safety

Volumn 16, Issue 3, 2007, Pages 250-258

  Tamim, H ^a   Tahami Monfared, A A ^b   LeLorier, J ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Exposure definition; Observational study; Pharmacoepidemiology; Protopathic bias

Indexed keywords

PROTON PUMP INHIBITOR;

ANALYTIC METHOD; ARTICLE; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; COMPARTMENT MODEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EXPOSURE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; STOMACH CANCER; STOMACH CARCINOGENESIS;

ANTI-ULCER AGENTS; BIAS (EPIDEMIOLOGY); CASE-CONTROL STUDIES; EPIDEMIOLOGIC STUDIES; HUMANS; LOGISTIC MODELS; MODELS, STATISTICAL; ODDS RATIO; PHARMACOEPIDEMIOLOGY; PROTON PUMPS; RESEARCH DESIGN; STOMACH NEOPLASMS; TIME FACTORS;

EID: 33947208503     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1360     Document Type: Article

References (24)

1. Strom BL (ed.). Pharmacoepidemiolog (3rd edn). John Wiley and Sons Ltd: Chichester, 2000.
2. Horwitz RI, Feinstein AR. The problem of "protopathic bias" in case-control studies. Am J Med 1980; 68(2): 255-258.
3. Gonzalez-Perez A, Garcia Rogriquez L, Lopez-Ridaura R. Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis. BMC Cancer 2003; 3(1): 28.
4. Welage LS, Berardi RR. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases. J Am Pharm Assoc 2000; 40: 52-62.
5. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun M. Cancer Statistics, 2003. CA-A Cancer J Clin 2003; 53: 5-26.
6. Roder D. The epidemiology of gastric cancer. Gastric Cancer 2002; 5(1): 5-11.
7. Régie l'Assurance Maladie du Québec. Health Ministry, Government of Québec, Québec: Régie de l'Assurance Maladie du Québec, Québec, 2003.
8. Tamblyn R, Lavoie G, Petrella L, Monette J. The use of prescription claims databases in pharmaco-epidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol 1995; 48: 999-1009.
9. Tamim HM, Duranceau A, Chen LQ, LeLorier J. Case-control study of the association between use of acid suppressive drugs and risk of gastric cancer (Abstract). Can J Clin Pharmacol 2005; 12(1).
10. Guidelines for ATC classification and DDD assignment. WHO Collaborating Centre for Drug Statistics Methodology: Oslo-Norway, 2001; ISBN 82 90312 32 6 (www.whocc.no/atcddd/).
11. SAS Institute, Inc. The SAS System for Windows Software, Release 8.2. SAS Institute, Inc.: NC, 1999.
12. Hanushek EA, Jackson JE. Statistical Methods for Social Scientists. Academic Press-New York: New York, 1977.
13. Lewis JB, Linzer DA. Estimating regression models in which the dependent variable is based on estimates. Pol Anal 2005; 13(4): 345-364.
14. Shively TC. Fast evaluation of the distribution of the Durbin-Watson and other invariant test statistics in time series regression. J Am Stat Assoc 1990; 85(411): 676-685.
15. Jacquez JA. Compartmental Analysis in Biology and Medicine. BioMedware: Ann Arbor, MI, 1996.
16. Jacquez JA. Modeling with Compartments. BioMedware: Ann Arbor, MI, 1999.
17. Akaike H. New look at statistical-model identification. IEEE Trans Automatic Control 1974; AC 19(6): 716-723.
18. Draper NR, Smith H. Applied Regression Analysis (2nd edn). Wiley & Sons: New York, 1981.
19. Grimshaw SD.Estimation of the linear-plateau segmented regression model in the presence of measurement error. Commun Stat Theory Methods 1992; 21: 2399-2413.
20. Hudson DJ. Fitting segmented curves whose join points have to be estimated. J Am Stat Assoc 1966; 61: 1097-1129.
21. Ulm KA statistical method for assessing a threshold in epidemiological studies. Stat Med 1991; 10: 341-349.
22. White H.A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroscedasticity. Econometrica 1980; 48(4): 817-838.
23. Drusano GL. Forrest A, Snyder MJ, Reed MD, Blumer JL. An evaluation of optimal sampling strategy and adaptive study design. Clin Pharmacol Ther 1988; 44: 232-238.
24. Drusano GL, Forrest A, Yuen G, Plaisance K, Leslie J. Optimal sampling theory: effect of error in a nominal parameter value on bias and precision of parameter estimation. Clin Pharmacol Ther 1994; 34: 967-974.